Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 3 results

Name	Type of Offering	Accepted Date
Adgero Biopharmaceuticals Holdings, Inc. See All Filings	D	2016-09-09 16:29:36 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers Aegis Capital Corp. CIK Number 0001657598 Filed Document 0000905718-16-001652 Exclusions or Exemptions 506b Accepted Date 2016-09-09 16:29:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Adgero Biopharmaceuticals Holdings, Inc. See All Filings	D	2016-04-19 00:00:00 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers Aegis Capital Corp. CIK Number 0001657598 Filed Document 0000905718-16-001355 Exclusions or Exemptions 506b Accepted Date 2016-04-19 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Adgero Biopharmaceuticals Holdings, Inc. See All Filings	D	2015-11-23 00:00:00 UTC
Amount To Be Raised $50,000 Associated Brokers / Dealers None CIK Number 0001657598 Filed Document 0001657598-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-11-23 00:00:00 UTC Type of Offering D Industry Investing Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity